vs
Side-by-side financial comparison of T Stamp Inc (IDAI) and Korro Bio, Inc. (KRRO). Click either name above to swap in a different company.
Korro Bio, Inc. is the larger business by last-quarter revenue ($1.3M vs $908.9K, roughly 1.4× T Stamp Inc). On growth, T Stamp Inc posted the faster year-over-year revenue change (-39.3% vs -43.1%). T Stamp Inc produced more free cash flow last quarter ($2.0M vs $-79.1M).
T Stamp Inc, trading under ticker IDAI, develops AI-powered identity verification, trust scoring, and fraud prevention solutions. It serves clients across fintech, healthcare, and e-commerce segments, primarily operating in North America to help organizations securely authenticate user identities and mitigate fraud risks.
Korro Bio, Inc. is a clinical-stage biotechnology company focused on developing innovative RNA editing therapies for rare and severe genetic diseases. It leverages its proprietary oligonucleotide platform to target disease-causing mutations, with core pipelines covering ophthalmology, respiratory and neuromuscular disorder segments, striving to address unmet medical needs for global patients.
IDAI vs KRRO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $908.9K | $1.3M |
| Net Profit | $-2.5M | — |
| Gross Margin | — | — |
| Operating Margin | -224.9% | — |
| Net Margin | -279.9% | — |
| Revenue YoY | -39.3% | -43.1% |
| Net Profit YoY | 57.7% | -136.1% |
| EPS (diluted) | $-0.37 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $908.9K | $1.3M | ||
| Q3 25 | $872.5K | $1.1M | ||
| Q2 25 | $812.7K | $1.5M | ||
| Q1 25 | $545.5K | $2.5M | ||
| Q4 24 | $1.5M | — | ||
| Q3 24 | $511.1K | $0 | ||
| Q2 24 | $500.4K | $0 | ||
| Q1 24 | $573.7K | $0 |
| Q4 25 | $-2.5M | — | ||
| Q3 25 | $-1.9M | $-18.1M | ||
| Q2 25 | $-1.7M | $-25.8M | ||
| Q1 25 | $-2.2M | $-23.4M | ||
| Q4 24 | $-6.0M | — | ||
| Q3 24 | $-1.3M | $-21.0M | ||
| Q2 24 | $-2.6M | $-21.8M | ||
| Q1 24 | $-2.7M | $-19.6M |
| Q4 25 | -224.9% | — | ||
| Q3 25 | -203.0% | -1764.9% | ||
| Q2 25 | -207.0% | -1863.2% | ||
| Q1 25 | -396.5% | -981.2% | ||
| Q4 24 | -81.2% | — | ||
| Q3 24 | -523.7% | — | ||
| Q2 24 | -524.7% | — | ||
| Q1 24 | -496.7% | — |
| Q4 25 | -279.9% | — | ||
| Q3 25 | -219.1% | -1657.0% | ||
| Q2 25 | -210.7% | -1765.1% | ||
| Q1 25 | -395.5% | -917.1% | ||
| Q4 24 | -401.5% | — | ||
| Q3 24 | -245.7% | — | ||
| Q2 24 | -519.3% | — | ||
| Q1 24 | -466.9% | — |
| Q4 25 | $-0.37 | — | ||
| Q3 25 | $-0.72 | $-1.92 | ||
| Q2 25 | $-0.69 | $-2.74 | ||
| Q1 25 | $-0.89 | $-2.49 | ||
| Q4 24 | $-3.14 | — | ||
| Q3 24 | $-1.06 | $-2.26 | ||
| Q2 24 | $-3.19 | $-2.43 | ||
| Q1 24 | $-3.97 | $-2.44 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $6.0M | $75.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $8.7M | $51.4M |
| Total Assets | $11.2M | $113.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $6.0M | $75.2M | ||
| Q3 25 | $5.4M | $92.5M | ||
| Q2 25 | $292.1K | $96.4M | ||
| Q1 25 | $1.1M | $115.0M | ||
| Q4 24 | $2.8M | — | ||
| Q3 24 | $598.0K | $137.0M | ||
| Q2 24 | $659.5K | $157.4M | ||
| Q1 24 | $816.7K | $138.8M |
| Q4 25 | $8.7M | $51.4M | ||
| Q3 25 | $6.1M | $99.0M | ||
| Q2 25 | $2.4M | $115.1M | ||
| Q1 25 | $4.1M | $139.0M | ||
| Q4 24 | $3.0M | — | ||
| Q3 24 | $5.4M | $179.6M | ||
| Q2 24 | $750.4K | $198.1M | ||
| Q1 24 | $1.4M | $151.4M |
| Q4 25 | $11.2M | $113.5M | ||
| Q3 25 | $11.2M | $161.6M | ||
| Q2 25 | $5.7M | $180.4M | ||
| Q1 25 | $6.6M | $202.2M | ||
| Q4 24 | $8.6M | — | ||
| Q3 24 | $10.6M | $243.5M | ||
| Q2 24 | $5.2M | $249.6M | ||
| Q1 24 | $5.6M | $198.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $2.0M | $-78.6M |
| Free Cash FlowOCF − Capex | $2.0M | $-79.1M |
| FCF MarginFCF / Revenue | 215.4% | -6120.7% |
| Capex IntensityCapex / Revenue | 0.8% | 40.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-5.7M | $-140.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.0M | $-78.6M | ||
| Q3 25 | $-4.0M | $-17.2M | ||
| Q2 25 | $-2.1M | $-19.2M | ||
| Q1 25 | $-1.5M | $-24.5M | ||
| Q4 24 | $-2.7M | — | ||
| Q3 24 | $-2.4M | $-16.1M | ||
| Q2 24 | $-1.6M | $-14.6M | ||
| Q1 24 | $-2.2M | $-21.9M |
| Q4 25 | $2.0M | $-79.1M | ||
| Q3 25 | $-4.0M | $-17.4M | ||
| Q2 25 | $-2.1M | $-19.4M | ||
| Q1 25 | $-1.6M | $-24.6M | ||
| Q4 24 | $-2.7M | — | ||
| Q3 24 | $-2.4M | $-21.0M | ||
| Q2 24 | $-1.6M | $-20.6M | ||
| Q1 24 | $-2.2M | $-27.5M |
| Q4 25 | 215.4% | -6120.7% | ||
| Q3 25 | -459.6% | -1592.1% | ||
| Q2 25 | -258.6% | -1326.6% | ||
| Q1 25 | -289.2% | -963.6% | ||
| Q4 24 | -182.9% | — | ||
| Q3 24 | -475.4% | — | ||
| Q2 24 | -320.9% | — | ||
| Q1 24 | -376.6% | — |
| Q4 25 | 0.8% | 40.1% | ||
| Q3 25 | 0.0% | 16.1% | ||
| Q2 25 | 0.2% | 9.6% | ||
| Q1 25 | 6.8% | 4.7% | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 0.7% | — | ||
| Q2 24 | 1.3% | — | ||
| Q1 24 | 0.5% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
